Skip to content
GLP-1 Scorecard
Menu
Site position #447

eMed

Published by GLP-1 ScorecardUpdated

eMed is a digital health platform best known for at-home diagnostics that now runs a clinician-supported GLP-1 weight management program.

Visit eMedWe may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.
Semaglutide
Not disclosed
Tirzepatide
Not disclosed
Coverage
Coverage not published
Brand-name
Not confirmed

Line eMed up against its closest alternatives. If you are considering a compounded option, read about whether compounded semaglutide is legit and safe.

Factor breakdown

These are recorded editorial marks, not a measure of clinical outcomes. Current prices and policies may differ from those used in the marks. See the methodology.

Cost value45/100
Dose & formulation40/100
Clinical oversight83/100
Labs & monitoring65/100
Fulfillment62/100
Contract terms55/100

Strengths

  • Prescribes FDA-approved branded GLP-1s (semaglutide and tirzepatide)
  • At-home blood collection makes lab work convenient
  • Clinician review and ongoing side-effect plus adherence support
  • Works with CVS Caremark so eligible employees can buy through benefits
  • Established digital health company with national scale

What to consider

  • Distributed mainly via employers, with limited direct cash-pay access
  • No public transparent monthly price for individuals
  • Eligibility and subsidy depend on what the employer chooses to cover
  • Best suited to workforces, not casual self-pay shoppers

Bottom line — Grade C

Best for: Shoppers who want employees whose company offers eMed GLP-1 benefits and wants at-home labs.

Site position #447 of 541. Commercial relationships affect placement, not the score. See our featured provider, CoreAge Rx (#1), for comparison.

Closest here

The rankings grading nearest eMed — the realistic shortlist.

The 18 rankings nearest this one

View full scorecard rankings →

Pricing/verification reflect eMed's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on eMed's site. Not medical advice; see our disclosure.

← Back to the scorecard